Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 6/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1615742 | 0.89 | POLB (0.37) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL15261081 | 0.86 | CYP4F2 (0.30) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL4400245 | 0.86 | CYP4F2 (0.37) | CYP4F2CYP4A11CYP3A4 | |
| SCHEMBL1802610 | 0.84 | CES2 (0.32) | ALDH1A1 | |
| SCHEMBL15270593 | 0.84 | CYP4F2 (0.34) | CYP4F2CYP4A11POLBGAANPSR1 | |
| SCHEMBL23312186 | 0.84 | ACHE (0.41) | ACHE | |
| SCHEMBL9171371 | 0.81 | ALDH1A1 (0.42) | ALDH1A1ACHE | |
| SCHEMBL13058214 | 0.80 | ACHE (0.33) | CYP4F2CYP4A11ACHE | |
| SCHEMBL1969735 | 0.80 | ACHE (0.33) | CYP4F2CYP4A11ALDH1A1ACHE | |
| SCHEMBL6521209 | 0.80 | ACHE (0.33) | CYP4F2CYP4A11ALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257553-A1 | SYNTHESIS OF SILANE COMPOUNDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-08-17 | — | — | US | disclosed |